Principle Wealth Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$748K Hold
4,772
0.04% 209
2026
Q1
$729K Sell
4,772
-28
-0.6% -$4.29K 0.04% 200
2025
Q4
$662K Sell
4,800
-22
-0.5% -$2.88K 0.04% 207
2025
Q3
$618K Sell
4,822
-25
-0.5% -$3.05K 0.04% 209
2025
Q2
$587K Buy
4,847
+600
+14% +$67.6K 0.04% 218
2025
Q1
$473K Hold
4,247
0.03% 232
2024
Q4
$413K Hold
4,247
0.03% 241
2024
Q3
$488K Hold
4,247
0.03% 227
2024
Q2
$452K Hold
4,247
0.03% 231
2024
Q1
$411K Hold
4,247
0.03% 244
2023
Q4
$429K Hold
4,247
0.04% 222
2023
Q3
$433K Hold
4,247
0.04% 214
2023
Q2
$429K Sell
4,247
-1,200
-22% -$120K 0.04% 216
2023
Q1
$501K Hold
5,447
0.05% 197
2022
Q4
$494K Buy
5,447
+125
+2% +$10.5K 0.06% 191
2022
Q3
$405K Hold
5,322
0.04% 206
2022
Q2
$450K Sell
5,322
-730
-12% -$64K 0.05% 202
2022
Q1
$531K Hold
6,052
0.06% 197
2021
Q4
$529K Hold
6,052
0.06% 201
2021
Q3
$495K Sell
6,052
-754
-11% -$67.8K 0.06% 198
2021
Q2
$621K Sell
6,806
-1,200
-15% -$107K 0.07% 176
2021
Q1
$684K Buy
8,006
+3,702
+86% +$332K 0.08% 158
2020
Q4
$406K Buy
+4,304
New +$376K 0.05% 195
2020
Q3
Sell
-521
Closed -$46K 336
2020
Q2
$46K Buy
+521
New +$45K 0.01% 285

Other funds holding NVS

Principle Wealth Partners's NVS Position: Q2 2026 in Review

Principle Wealth Partners held its Novartis (NVS) position steady in Q2 2026 at 4,772 shares worth $748K. The position accounts for 0.04% of the portfolio, ranked #209.

Principle Wealth Partners first reported a position in NVS in Q2 2020 and has held it in 24 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Principle Wealth Partners held 4,772 shares of Novartis worth $748K as of Q2 2026.
  • Principle Wealth Partners left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.04% of Principle Wealth Partners's portfolio in Q2 2026, its #209 holding.
  • Principle Wealth Partners first reported a position in Novartis in Q2 2020 and has held it in 24 quarters since.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Principle Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.